Skip to content

Envoy Medical COCH Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

CalAmp logo
CalAmpCAMP
$0-100%
Centerspace logo
CenterspaceCSR
$43K-93.9%
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
$0
Empire State Realty Trust logo
Empire State Realty TrustESRT
$5.99M+278%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$28.57M
Blaize Holdings, Inc. Common Stock logo
Blaize Holdings, Inc. Common StockBZAI
$0-100%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's exchange offer (note 12)?
Envoy Medical (COCH) reported exchange offer (note 12) of $290.5K in Q4 2024.
How has Envoy Medical's exchange offer (note 12) changed year-over-year?
Envoy Medical's exchange offer (note 12) decreased by 95.8% year-over-year, from $6.87M to $290.5K.
What does exchange offer (note 12) mean?
Quantifies the value of debt or other securities converted into common equity during the reporting period. This metric is a key indicator of balance sheet deleveraging and the resulting dilution of existing shareholders.